Finance and markets: business, quotes, gold, energy and releases.
Found 4752 articles
A fresh $2.5 million injection from a Pentagon-managed grant has pushed Armata Pharmaceuticals shares up by 5% in premarket trading. The funding, which brings the company’s total award to $28.7 million, is earmarked for the final stages of development for a specialized treatment targeting complicated Staphylococcus aureus bacteremia.
Accenture is injecting an additional $2 billion into its stock buyback program, a sharp pivot following an 18% single-day share price collapse last Thursday. The consulting giant now intends to repurchase $2.3 billion in equity through the end of its fiscal fourth quarter on August 31.
Rafael Oliveira will take the helm of the world’s second-largest brewer on October 1, ending months of speculation regarding the successor to outgoing CEO Dolf van den Brink. The appointment of the JDE Peet’s executive marks a strategic shift for the Amsterdam-listed company as it navigates a period of stagnant sales.
Investors pushed Bunzl shares up 1.2% to 24.94 pounds in morning trade following the company’s decision to lift its 2026 revenue outlook. Bolstered by robust first-half performance and improved margins, the U.K. distribution group now anticipates steady growth driven by consistent acquisitions and favorable inflationary support.
Fuji Media Holdings shifted to a net profit of 6.50 billion yen for the fiscal year ending March 31, marking a sharp recovery from the 20.13 billion yen loss reported during the previous period. The Tokyo-based media group stabilized its financial position even as operating metrics faced significant downward pressure.
Cybertrust Japan posted a net profit of 989 million yen for the fiscal year ending March 31, 2026, marking a steady climb from the 969 million yen recorded the previous year. The company’s financial performance reflects broader gains in revenue and operating margins under Japanese accounting standards.
Sanrio Co. reported a significant fiscal year performance, with net profit climbing to 54.61 billion yen for the period ending March 31, compared to 41.73 billion yen in the previous year. The results, anchored in Japanese accounting standards, reflect a robust expansion in both revenue and operating margins for the company.
Suzuyo Shinwart Corp. reported a revenue increase to 20.67 billion yen for the fiscal year ending March 31, 2026, even as the company’s net profit slipped to 1.08 billion yen from 1.11 billion yen the previous year, according to its latest financial filing under Japanese accounting standards.
For every single day of disruption in the Strait of Hormuz, global energy supply chains require three days to normalize, leaving Asian markets trapped in a cycle of high costs. Even as tankers resume transit following the U.S.-Iran peace deal, the lingering damage to infrastructure continues to stifle regional growth.
A wave of selling hit global markets overnight, dragging major indices across Asia and Europe into the red while U.S. futures signaled a nervous start to the trading day. Investors pulled back from equities as concerns rippled across borders, pushing benchmark bond yields lower alongside a slump in oil prices.
Japan Display reported a net loss of 19.81 billion yen for the fiscal year ending March 31, a significant improvement from the 78.22 billion yen deficit recorded the previous year. Despite the smaller bottom-line shortfall, the company faced a substantial contraction in top-line performance as annual revenue dropped to 132.33 billion yen.
TotalEnergies SE executed a significant share repurchase program between June 15 and June 19, 2026, acquiring 1,872,668 of its own shares. The operation, authorized by shareholders at the May 2026 general meeting, involved a total investment of approximately 135 million euros across the XPAR and CEUX markets.
Consumer prices in Singapore maintained a steady 1.8% annual growth rate in May, defying expectations of an uptick despite persistent energy market instability. The figure matched April’s pace, coming in slightly below the 1.9% consensus forecast, even as supply chain disruptions from the Middle East continue to pressure global input costs.
A 48 percent collapse in early trading greeted HJ Science on Tuesday, marking a brutal start for the Chengdu-based biotech firm. After raising 1.11 billion Hong Kong dollars—roughly 141.6 million U.S. dollars—in its initial public offering, the company saw investor confidence evaporate against the backdrop of an unforgiving pharmaceutical landscape.
A sharp deceleration in China’s 618 shopping festival growth underscores a deepening malaise in domestic consumption. Online sales climbed just 4% to 934 billion yuan during the month-long event, a stark contrast to the 15% expansion seen last year, as shoppers increasingly resist the lure of traditional e-commerce promotions.
Shares of Shenzhen Senior Technology Material climbed 49% during their Tuesday morning debut in Hong Kong, highlighting robust investor demand for battery-chain suppliers. The company, which raised 1.34 billion Hong Kong dollars, settled at a 33% gain, defying a simultaneous downturn for its stock listed on the mainland exchange.
KYB Corporation reported a sharp surge in annual earnings for the fiscal year ending March 31, with net profit nearly doubling to 29.04 billion yen. The automotive component manufacturer saw its bottom line expand significantly from the 14.90 billion yen recorded in the previous year, driven by steady gains across its operations.
With global investors clamoring for Chinese tech exposure, Anker Innovations has opened its book-building process for a Hong Kong listing. The electronics manufacturer intends to raise 4.63 billion Hong Kong dollars, aiming to solidify its reach beyond its existing presence on the Shenzhen Stock Exchange.
A turbulent after-hours session saw market valuations for Primoris Services and Nexentis Technologies collapse on Monday, as investors reacted to a combination of lowered financial guidance and dilutive equity offerings, while Avis Budget Group secured a significant legal windfall that pushed its stock price higher.
A potential $1.33 billion investment in a Dallas operational hub highlights Morgan Stanley’s growth strategy, even as financial markets navigate an era of heightened uncertainty following Federal Reserve Chairman Kevin Warsh’s signal that he intends to overhaul the central bank’s public communication framework.
U.S. communications services stocks are leading market declines today as persistent anxieties regarding the conflict between the United States and Iran dampen investor sentiment. Traders are weighing the potential fallout of these geopolitical hostilities on broader economic growth and inflation trajectories, driving a flight from risk-sensitive media and technology assets.
As oil prices soften and diplomatic efforts to secure the Strait of Hormuz persist, the utilities sector is seeing a renewed market surge. Investors are eyeing a shift in energy priorities, with Canada leading the charge by formalizing an ambitious strategy to expand its nuclear power infrastructure.
A cooling sentiment gripped the Nasdaq-100 as investors recalibrated expectations for artificial intelligence amid the shadow of unresolved Middle East tensions. The shift hit newcomer stocks hard, with CoreWeave and Rocket Lab suffering sharp declines during their debut session as part of the index, signaling a restless market environment.
Craig Sasser will step into the role of chief operating officer at Comfort Systems USA on July 1, marking a significant leadership transition for the national HVAC and electrical contractor. His appointment arrives alongside the promotion of Briston Blair, who will assume the newly defined position of chief strategy and innovation officer.
Thirteen lives were lost in a devastating blast at a primary Qatari natural gas facility, an incident that has rattled global energy markets even as shipping traffic through the Strait of Hormuz shows tentative signs of recovery following diplomatic progress between the United States and Iran.
Pfizer’s late-stage clinical trial for the experimental lung cancer drug sigvotatug vedotin has failed to meet its primary goal. The study, aimed at treating advanced non-small cell lung cancer, showed no statistically significant improvement in overall patient survival when measured against the standard chemotherapy treatment, docetaxel.
After two decades of leadership, Guardian Pharmacy Services is reshuffling its top brass as co-founder David Morris transitions to chief operating officer. The move follows the planned retirement of Kendall Forbes, who has managed the company's sales and operations since its inception in 2004, marking a significant shift in corporate oversight.
After two decades of steering NVE through its evolution into a spintronics powerhouse, Daniel Baker is stepping down as chief executive officer. The company confirmed Monday that Peter Eames, currently the head of advanced technology, will assume the top leadership post on August 6.
Orchid Island Capital has bolstered its capital return strategy, with the board authorizing the repurchase of an additional 25 million shares. This move brings the firm's total buyback capacity to 26.6 million shares, representing approximately 13.3% of the company's currently outstanding common stock.
A potential thaw in U.S.-Iran relations has nudged materials stocks upward, as markets weigh the prospect of restored global supply chains. Gold, copper, and aluminum prices responded with modest gains, reflecting heightened sensitivity to the diplomatic maneuvers currently unfolding across the Middle East.